Literature DB >> 21260944

RB in breast cancer: differential effects in estrogen receptor-positive and estrogen receptor-negative disease.

Elizabeth A Musgrove, Robert L Sutherland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21260944      PMCID： PMC3233479          DOI： 10.4161/cc.9.23.13889

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  69 in total

Review 1.  Stabilizers and destabilizers controlling cell cycle oscillators.

Authors:  Daniele Guardavaccaro; Michele Pagano
Journal:  Mol Cell       Date:  2006-04-07       Impact factor: 17.970

2.  Epigenetic regulation of TTF-I-mediated promoter-terminator interactions of rRNA genes.

Authors:  Attila Németh; Sylvain Guibert; Vijay Kumar Tiwari; Rolf Ohlsson; Gernot Längst
Journal:  EMBO J       Date:  2008-03-20       Impact factor: 11.598

3.  Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.

Authors:  Zhe Jiang; Tao Deng; Robert Jones; Huiqin Li; Jason I Herschkowitz; Jeff C Liu; Victor J Weigman; Ming-Sound Tsao; Timothy F Lane; Charles M Perou; Eldad Zacksenhaus
Journal:  J Clin Invest       Date:  2010-08-02       Impact factor: 14.808

4.  The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression.

Authors:  A Borg; Q X Zhang; P Alm; H Olsson; G Sellberg
Journal:  Cancer Res       Date:  1992-05-15       Impact factor: 12.701

5.  Expression of MAP3 kinase COT1 is up-regulated by 1,25-dihydroxyvitamin D3 in parallel with activated c-jun during differentiation of human myeloid leukemia cells.

Authors:  Xuening Wang; George P Studzinski
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-19       Impact factor: 4.292

6.  Mutants of S. cerevisiae defective in the maintenance of minichromosomes.

Authors:  G T Maine; P Sinha; B K Tye
Journal:  Genetics       Date:  1984-03       Impact factor: 4.562

Review 7.  RB in breast cancer: at the crossroads of tumorigenesis and treatment.

Authors:  Emily E Bosco; Erik S Knudsen
Journal:  Cell Cycle       Date:  2007-03-07       Impact factor: 4.534

8.  An Smc3 acetylation cycle is essential for establishment of sister chromatid cohesion.

Authors:  Frederic Beckouët; Bin Hu; Maurici B Roig; Takashi Sutani; Makiko Komata; Pelin Uluocak; Vittorio L Katis; Katsuhiko Shirahige; Kim Nasmyth
Journal:  Mol Cell       Date:  2010-09-10       Impact factor: 17.970

9.  3'-End formation of transcripts from the yeast rRNA operon.

Authors:  A E Kempers-Veenstra; J Oliemans; H Offenberg; A F Dekker; P W Piper; R J Planta; J Klootwijk
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

10.  The ELG1 clamp loader plays a role in sister chromatid cohesion.

Authors:  Oren Parnas; Adi Zipin-Roitman; Yuval Mazor; Batia Liefshitz; Shay Ben-Aroya; Martin Kupiec
Journal:  PLoS One       Date:  2009-05-11       Impact factor: 3.240
View more
  7 in total

Review 1.  Mechanisms of resistance to estrogen receptor modulators in ER+/HER2- advanced breast cancer.

Authors:  Jin Zhang; Qianying Wang; Qing Wang; Jiangran Cao; Jiafu Sun; Zhengmao Zhu
Journal:  Cell Mol Life Sci       Date:  2019-08-30       Impact factor: 9.261

2.  The cellular selection between apoptosis and autophagy: roles of vitamin D, glucose and immune response in diabetic nephropathy.

Authors:  Magda Hamzawy; Sarah Ali Abdelhameed Gouda; Laila Rashid; Mary Attia Morcos; Heba Shoukry; Nivin Sharawy
Journal:  Endocrine       Date:  2017-09-09       Impact factor: 3.633

Review 3.  Palbociclib: A breakthrough in breast carcinoma in women.

Authors:  Ajay Kumar Gupta; Sushil Sharma; Navdeep Dahiya; D B S Brashier
Journal:  Med J Armed Forces India       Date:  2016-01-26

4.  Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine.

Authors:  William H Chappell; Stephen L Abrams; Richard A Franklin; Michelle M LaHair; Giuseppe Montalto; Melchiorre Cervello; Alberto M Martelli; Ferdinando Nicoletti; Saverio Candido; Massimo Libra; Jerry Polesel; Renato Talamini; Michele Milella; Agostino Tafuri; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2012-11-16       Impact factor: 4.534

5.  Overcoming Endocrine Resistance in Hormone-Receptor Positive Advanced Breast Cancer-The Emerging Role of CDK4/6 Inhibitors.

Authors:  Ciara C O'Sullivan
Journal:  Int J Cancer Clin Res       Date:  2015-10-14

Review 6.  Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Richard A Franklin; Giuseppe Montalto; Melchiorre Cervello; Massimo Libra; Saverio Candido; Grazia Malaponte; Maria C Mazzarino; Paolo Fagone; Ferdinando Nicoletti; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Francesca Chiarini; Camilla Evangelisti; Lucio Cocco; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-10

Review 7.  Palbociclib: an evidence-based review of its potential in the treatment of breast cancer.

Authors:  Karen A Cadoo; Ayca Gucalp; Tiffany A Traina
Journal:  Breast Cancer (Dove Med Press)       Date:  2014-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.